Equine Adipose-Derived Mesenchymal Stromal Cells Release Extracellular Vesicles Enclosing Different Subsets of Small RNAs.
Journal
Stem cells international
ISSN: 1687-966X
Titre abrégé: Stem Cells Int
Pays: United States
ID NLM: 101535822
Informations de publication
Date de publication:
2019
2019
Historique:
received:
06
08
2018
revised:
13
11
2018
accepted:
19
12
2018
entrez:
24
4
2019
pubmed:
24
4
2019
medline:
24
4
2019
Statut:
epublish
Résumé
Equine adipose-derived mesenchymal stromal cells (e-AdMSC) exhibit attractive proregenerative properties strongly related to the delivery of extracellular vesicles (EVs) that enclose different kinds of molecules including RNAs. In this study, we investigated small RNA content of EVs produced by e-AdMSC with the aim of speculating on their possible biological role. EVs were obtained by ultracentrifugation of the conditioned medium of e-AdMSC of 4 subjects. Transmission electron microscopy and scanning electron microscopy were performed to assess their size and nanostructure. RNA was isolated, enriched for small RNAs (<200 nt), and sequenced by Illumina technology. After bioinformatic analysis with state-of-the-art pipelines for short sequences, mapped reads were used to describe EV RNA cargo, reporting classes, and abundances. Enrichment analyses were performed to infer involved pathways and functional categories. Electron microscopy showed the presence of vesicles ranging in size from 30 to 300 nm and expressing typical markers. RNA analysis revealed that ribosomal RNA was the most abundant fraction, followed by small nucleolar RNAs (snoRNAs, 13.67%). Miscellaneous RNA (misc_RNA) reached 4.57% of the total where Y RNA, RNaseP, and vault RNA represented the main categories. miRNAs were sequenced at a lower level (3.51%) as well as protein-coding genes (1.33%). Pathway analyses on the protein-coding fraction revealed a significant enrichment for the "ribosome" pathway followed by "oxidative phosphorylation." Gene Ontology analysis showed enrichment for terms like "extracellular exosome," "organelle envelope," "RNA binding," and "small molecule metabolic process." The miRNA target pathway analysis revealed the presence of "signaling pathways regulating pluripotency of stem cells" coherent with the source of the samples. We herein demonstrated that e-AdMSC release EVs enclosing different subsets of small RNAs that potentially regulate a number of biological processes. These findings shed light on the role of EVs in the context of MSC biology.
Sections du résumé
BACKGROUND
BACKGROUND
Equine adipose-derived mesenchymal stromal cells (e-AdMSC) exhibit attractive proregenerative properties strongly related to the delivery of extracellular vesicles (EVs) that enclose different kinds of molecules including RNAs. In this study, we investigated small RNA content of EVs produced by e-AdMSC with the aim of speculating on their possible biological role.
METHODS
METHODS
EVs were obtained by ultracentrifugation of the conditioned medium of e-AdMSC of 4 subjects. Transmission electron microscopy and scanning electron microscopy were performed to assess their size and nanostructure. RNA was isolated, enriched for small RNAs (<200 nt), and sequenced by Illumina technology. After bioinformatic analysis with state-of-the-art pipelines for short sequences, mapped reads were used to describe EV RNA cargo, reporting classes, and abundances. Enrichment analyses were performed to infer involved pathways and functional categories.
RESULTS
RESULTS
Electron microscopy showed the presence of vesicles ranging in size from 30 to 300 nm and expressing typical markers. RNA analysis revealed that ribosomal RNA was the most abundant fraction, followed by small nucleolar RNAs (snoRNAs, 13.67%). Miscellaneous RNA (misc_RNA) reached 4.57% of the total where Y RNA, RNaseP, and vault RNA represented the main categories. miRNAs were sequenced at a lower level (3.51%) as well as protein-coding genes (1.33%). Pathway analyses on the protein-coding fraction revealed a significant enrichment for the "ribosome" pathway followed by "oxidative phosphorylation." Gene Ontology analysis showed enrichment for terms like "extracellular exosome," "organelle envelope," "RNA binding," and "small molecule metabolic process." The miRNA target pathway analysis revealed the presence of "signaling pathways regulating pluripotency of stem cells" coherent with the source of the samples.
CONCLUSION
CONCLUSIONS
We herein demonstrated that e-AdMSC release EVs enclosing different subsets of small RNAs that potentially regulate a number of biological processes. These findings shed light on the role of EVs in the context of MSC biology.
Identifiants
pubmed: 31011332
doi: 10.1155/2019/4957806
pmc: PMC6442443
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4957806Références
Transl Stroke Res. 2019 Oct;10(5):509-521
pubmed: 30341718
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652):
pubmed: 25135963
Cardiovasc Res. 2008 Sep 1;79(4):581-8
pubmed: 18550634
Bioessays. 2013 Jan;35(1):46-54
pubmed: 23180440
J Extracell Vesicles. 2015 May 29;4:26760
pubmed: 26027894
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Database (Oxford). 2016 Jun 23;2016:
pubmed: 27337980
Stem Cells Dev. 2014 Jun 1;23(11):1233-44
pubmed: 24367916
BMC Genomics. 2012 Aug 14;13:390
pubmed: 22892049
Front Immunol. 2014 Nov 04;5:556
pubmed: 25414703
Leukemia. 2012 Sep;26(9):2052-60
pubmed: 22522792
Nat Commun. 2015 Oct 07;6:8472
pubmed: 26442449
BMC Genomics. 2018 May 29;19(1):408
pubmed: 29843592
Vet J. 2013 Jan;195(1):98-106
pubmed: 22841420
J Extracell Vesicles. 2019 Aug 27;8(1):1635420
pubmed: 31497264
Cell Oncol (Dordr). 2017 Oct;40(5):457-470
pubmed: 28741069
Vet J. 2014 Nov;202(2):361-6
pubmed: 25241947
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
J Extracell Vesicles. 2017 Mar 7;6(1):1286095
pubmed: 28326170
Sci Rep. 2015 Feb 26;5:8588
pubmed: 25715874
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Exp Mol Med. 2018 Sep 10;50(9):1-12
pubmed: 30201949
BMC Genomics. 2013 May 10;14:319
pubmed: 23663360
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1625-34
pubmed: 26957605
Vet Surg. 2014 Mar;43(3):255-65
pubmed: 24433318
Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):499-506
pubmed: 21839521
Bioessays. 2011 Aug;33(8):565-73
pubmed: 21618561
J Cell Sci. 2016 Jun 1;129(11):2182-9
pubmed: 27252357
Sci Rep. 2016 Mar 02;6:22519
pubmed: 26931825
Stem Cell Res Ther. 2013 Apr 25;4(2):34
pubmed: 23618405
Commun Integr Biol. 2010 Sep;3(5):447-50
pubmed: 21057637
Mol Biol Cell. 2002 Dec;13(12):4279-95
pubmed: 12475952
Stem Cells Transl Med. 2018 Jan;7(1):98-108
pubmed: 29063737
Sci Rep. 2016 Mar 29;6:23772
pubmed: 27021515
Oncotarget. 2017 Jul 11;8(28):45200-45212
pubmed: 28423355
Biochimie. 2011 Nov;93(11):1987-92
pubmed: 21664409
Histol Histopathol. 2015 May;30(5):549-57
pubmed: 25418078
Bioinformatics. 2017 Feb 15;33(4):592-593
pubmed: 27797767
Gene. 2014 Nov 1;551(1):55-64
pubmed: 25158130
Stem Cell Res Ther. 2015 Nov 11;6:212
pubmed: 26560482
J Vasc Res. 2009;46(6):527-40
pubmed: 19571573
RNA Biol. 2017 Dec 2;14(12):1683-1689
pubmed: 28816640
Curr Biol. 2012 Jan 24;22(2):135-41
pubmed: 22226745
Stem Cell Res Ther. 2014 Jun 10;5(3):76
pubmed: 24915963
Cytotherapy. 2018 Jan;20(1):62-73
pubmed: 29107738
Stem Cells. 2012 Apr;30(4):643-54
pubmed: 22232059
Stem Cells Dev. 2016 Apr 15;25(8):610-21
pubmed: 26914245
Stem Cell Res Ther. 2015 Jul 01;6:127
pubmed: 26129847
Cell Mol Neurobiol. 2016 Apr;36(3):301-12
pubmed: 27053351
Regen Med. 2014;9(5):673-85
pubmed: 25372081
Am J Transl Res. 2017 Jul 15;9(7):3499-3513
pubmed: 28804566
Oncogene. 2011 Feb 17;30(7):806-21
pubmed: 20956944
Stem Cell Res Ther. 2016 Nov 18;7(1):169
pubmed: 27863532
Cell Mol Life Sci. 2011 Aug;68(16):2667-88
pubmed: 21560073
Cold Spring Harb Symp Quant Biol. 2006;71:329-34
pubmed: 17381313
Stem Cells Dev. 2012 Dec 10;21(18):3289-97
pubmed: 22839741
Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1 Suppl):61-8
pubmed: 24046950
Biochimie. 2002 Aug;84(8):775-90
pubmed: 12457565
Adv Mater. 2016 Jul;28(27):5542-52
pubmed: 26678528